🔎 Trials Near Me

Home › Ulcerative Colitis › Arizona › Phoenix

Ulcerative Colitis clinical trials in Phoenix, AZ

6 studies for Ulcerative Colitis are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • Elite Clinical Studies /ID# 280477, Phoenix
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07697456

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 2
  • Valleywise Health Medical Center, Phoenix
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

RecruitingPhase 3
  • Phoenix Children's Hospital /ID# 273015, Phoenix
Ages 2 to 17 · All sexes · Updated Sep 22, 2026 · NCT07071519

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

RecruitingPhase 3
  • Phoenix Children's Hospital, Phoenix
Ages 2 to 17 · All sexes · Updated Aug 3, 2026 · NCT06100289

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RecruitingPhase 3
  • Phoenix Childrens Hospital, Phoenix
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RecruitingPhase 3
  • Phoenix Childrens Hospital - Thomas Rd - PIN, Phoenix
Ages 2 and older · All sexes · Updated May 7, 2026 · NCT05442567

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in Phoenix

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.